- 专利标题： Musculoskeletal stem cell and medium for inducing differentiation of musculoskeletal stem cell
-
申请号： US16392524申请日： 2019-04-23
-
公开(公告)号： US10576106B2公开(公告)日： 2020-03-03
- 发明人: Myung-Kwan Han
- 申请人： CELLATOZ THERAPEUTICS, INC.
- 申请人地址： KR Gyeonggi
- 专利权人： Cellatoz Therapeutics, Inc.
- 当前专利权人： Cellatoz Therapeutics, Inc.
- 当前专利权人地址： KR Gyeonggi
- 代理机构： Sterne, Kessler, Goldstein & Fox P.L.L.C.
- 优先权： KR10-2017-0139143 20171025
- 主分类号： A61K35/34
- IPC分类号： A61K35/34 ; C12N5/0775 ; A61P21/00 ; A61K35/32 ; C12N5/00 ; C12N5/0735 ; C12N5/077 ; C12N5/074
摘要：
The present disclosure relates to a novel musculoskeletal stem cell (MSSC) differentiated from an ESC (embryonic stem cell) or an iPSC (induced pluripotent stem cell). The musculoskeletal stem cell of the present disclosure can be easily induced from a human embryonic stem cell or a human-derived pluripotent stem cell and can be effectively differentiated not only into bone but also into cartilage, tendon and muscle. Accordingly, it can be usefully used for prevention or treatment of various musculoskeletal diseases.
公开/授权文献
信息查询
IPC分类:
